Ferritin in the cerebrospinal fluid of patients with Parkinson's disease

Pall, H S; Brailsford, S; Williams, A C; Lunec, J; Blake, D R
September 1990
Journal of Neurology, Neurosurgery & Psychiatry;Sep1990, Vol. 53 Issue 9, p803
Academic Journal
No abstract available.


Related Articles

  • Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients. Jiguang Guo; Zhongwu Sun; Shifu Xiao; Dongping Liu; Guohua Jin; Ersong Wang; Jiangning Zhou; Jiawei Zhou // Cell Research;Dec2009, Vol. 19 Issue 12, p1401 

    A letter to the editor is presented in response to an article on proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients that was published in the December 1, 2009 issue.

  • Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies. Goldstein, David S.; Holmes, Courtney; Sharabi, Yehonatan // Brain: A Journal of Neurology;Jun2012, Vol. 135 Issue 6, p1900 

    Central catecholamine deficiency characterizes α-synucleinopathies such as Parkinson’s disease. We hypothesized that cerebrospinal fluid levels of neuronal metabolites of catecholamines provide neurochemical biomarkers of these disorders. To test this hypothesis we measured...

  • DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease. Zhen Hong; Min Shi; Chung, Kathryn A.; Quinn, Joseph F.; Peskind, Elaine R.; Galasko, Douglas; Jankovic, Joseph; Zabetian, Cyrus P.; Leverenz, James B.; Baird, Geoffrey; Montine, Thomas J.; Hancock, Aneeka M.; Hyejin Hwang; Pan, Catherine; Bradner, Joshua; Kang, Un J.; Jensen, Poul H.; Jing Zhang // Brain: A Journal of Neurology;Mar2010, Vol. 133 Issue 3, p713 

    Biomarkers are urgently needed for the diagnosis and monitoring of disease progression in Parkinson’s disease. Both DJ-1 and α-synuclein, two proteins critically involved in Parkinson’s disease pathogenesis, have been tested as disease biomarkers in several recent studies with...

  • Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia. Compta, Yaroslau; Santamaria, Joan; Ratti, Luca; Tolosa, Eduardo; Iranzo, Alex; Muñoz, Esteban; Valldeoriola, Francesc; Casamitjana, Roser; Ríos, Jose; Marti, Maria J. // Brain: A Journal of Neurology;Dec2009, Vol. 132 Issue 12, p3308 

    Excessive daytime sleepiness is common in Parkinson's disease and has been associated with Parkinson's disease-related dementia. Narcoleptic features have been observed in Parkinson's disease patients with excessive daytime sleepiness and hypocretin cell loss has been found in the hypothalamus...

  • Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. Pisani, Valerio; Stefani, Alessandro; Pierantozzi, Mariangela; Natoli, Silvia; Stanzione, Paolo; Franciotta, Diego; Pisani, Pisani // Journal of Neuroinflammation;2012, Vol. 9 Issue 1, p188 

    Background: Alterations in blood-brain barrier permeability have been proposed to represent a relevant factor contributing to Parkinson's disease progression. However, few studies have addressed this issue in patients at different stages of disease. Methods: Albumin was measured in cerebrospinal...

  • Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Stuendl, Anne; Kunadt, Marcel; Kruse, Niels; Bartels, Claudia; Moebius, Wiebke; Danzer, Karin M.; Mollenhauer, Brit; Schneider, Anja // Brain: A Journal of Neurology;2/1/2016, Vol. 139 Issue 2, p481 

    Extracellular α-synuclein has been proposed as a crucial mechanism for induction of pathological aggregate formation in previously healthy cells. In vitro, extracellular α-synuclein is partially associated with exosomal vesicles. Recently, we have provided evidence that exosomal...

  • CSF fistula secondary to sphenoid meningoencephalocele. D'Antonio, Michael; Palacios, Enrique; Scheuemann, Christian // ENT: Ear, Nose & Throat Journal;Dec2003, Vol. 82 Issue 12, p912 

    Presents the case of a patient with cerebrospinal fluid secondary to sphenoid meningoencephalocele. Possible cause of the disease; Diagnosis; Information on the treatment of the patient.

  • BIOMARCADORES NO LÍQUIDO CEFALORRAQUIDIANO. COSTA, Andreia Gomes da; GAGO, Miguel Fernandes; GARRETT, Carolina // Acta Medica Portuguesa;SUP2011, Vol. 24 Issue S4, p761 

    In current medical practice, the diagnosis of Parkinson's disease remains essentially clinical. This practice determines that the diagnosis of Parkinson's disease is done in an already advanced neuropathological stage of the disease. The aim of this study is to review the validity of...

  • Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease. Zhang, Jing; Mattison, Hayley; Liu, Changqin; Ginghina, Carmen; Auinger, Peggy; McDermott, Michael; Stewart, Tessandra; Kang, Un; Cain, Kevin; Shi, Min // Acta Neuropathologica;Nov2013, Vol. 126 Issue 5, p671 

    Tau gene has been consistently associated with the risk of Parkinson disease in recent genome wide association studies. In addition, alterations of the levels of total tau, phosphorylated tau [181P], and amyloid beta 1-42 in cerebrospinal fluid have been reported in patients with sporadic...

  • Lupus Meningitis. Keeffe, Emmet B.; Bardana Jr., Emil J.; Harbeck, Ronald J.; Pirofsky, Bernard; Carr, Ronald I. // Annals of Internal Medicine;Jan74, Vol. 80 Issue 1, p58 

    Describes a patient with systemic lupus erythematosus who presented with acute meningitis and cerebrospinal fluid-polymorphonuclear pleocytosis, in whom extensive study failed to show a viral. Nature of central nervous system disease; Characterization of cerebrospinal fluid; Results of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics